New eye injection strategy aims to halt rapid vision loss
NCT ID NCT07187804
Summary
This study is testing if a medication called faricimab, given as eye injections, can better control a severe and fast-progressing type of age-related macular degeneration (AMD). Researchers want to see if using a specific, careful treatment schedule can preserve vision and prevent further damage in 30 patients. The goal is to find a more effective long-term management strategy for this condition, which carries a high risk of profound vision loss.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (ARMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kim's Eye Hospital
Seoul, 150-034, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.